Results 151 to 160 of about 110,071 (192)
Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus. [PDF]
Vaccines (Basel)Liu S +16 more
europepmc +1 more source
Immunoinformatics-based strategies for developing DNA and mRNA vaccines against monkeypox virus (MPXV). [PDF]
Virol JKhan S +9 more
europepmc +1 more source
Heterologous Prime-Boost Vaccination with GRA35-Encoding DNA and mRNA Vaccines Enhances Protective Immunity Against <i>Toxoplasma gondii</i> Infection in Mouse Models. [PDF]
MicroorganismsChen S, Li R, Zhu Y, Sun J, Chen J.
europepmc +1 more source
Innovation in mRNA Vaccines and RNAi via Protein Nanocages. [PDF]
Vaccines (Basel)Ahmadivand S.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nucleic Acid Therapeutics, 2022
The success of mRNA vaccines against COVID-19 is nothing short of a medical revolution. Given its chemical lability the use of mRNA as a therapeutic has been counterintuitive and met with skepticism. The development of mRNA-based COVID-19 vaccines was the culmination of long and painstaking efforts by many investigators spanning ...
Eli, Gilboa +2 more
openaire +2 more sources
The success of mRNA vaccines against COVID-19 is nothing short of a medical revolution. Given its chemical lability the use of mRNA as a therapeutic has been counterintuitive and met with skepticism. The development of mRNA-based COVID-19 vaccines was the culmination of long and painstaking efforts by many investigators spanning ...
Eli, Gilboa +2 more
openaire +2 more sources
Nature Biotechnology, 2021
The concept of developing mRNA as vaccine platform evolved over the last decades. mRNA uses host cells for antigen production, can induce B and T cell responses and does not rely on unwanted antigens that may interfere with booster doses like vector vaccines.
openaire +3 more sources
The concept of developing mRNA as vaccine platform evolved over the last decades. mRNA uses host cells for antigen production, can induce B and T cell responses and does not rely on unwanted antigens that may interfere with booster doses like vector vaccines.
openaire +3 more sources
Development of mRNA Vaccines: Scientific and Regulatory Issues
Vaccines, 2021 The global research and development of mRNA vaccines have been prodigious over the past decade, and the work in this field has been stimulated by the urgent need for rapid development of vaccines in response to an emergent disease such as the current ...
Ivana Knežević +2 more
exaly +2 more sources
Nature Biotechnology, 2012
An influenza vaccine made of stabilized mRNA may allow vaccine design and manufacture to keep pace with viral evolution.
Sook-San, Wong, Richard J, Webby
openaire +2 more sources
An influenza vaccine made of stabilized mRNA may allow vaccine design and manufacture to keep pace with viral evolution.
Sook-San, Wong, Richard J, Webby
openaire +2 more sources